Skip Navigation


Journal of Tropical Pediatrics Advance Access first published online on December 2, 2005
This version published online on December 9, 2005

Journal of Tropical Pediatrics, doi:10.1093/tropej/fmi110
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
52/4/254    most recent
fmi110v3
fmi110v2
fmi110v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ben Quashie, N.
Right arrow Articles by Kurtzhals, J. A.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ben Quashie, N.
Right arrow Articles by Kurtzhals, J. A.L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Original Papers

Factors Contributing to the Development of Anaemia in Plasmodium falciparum Malaria: What about Drug-Resistant Parasites?

Neils Ben Quashie 1 *, Bartholomew D. Akanmori 2, David Ofori-Adjei 2, Bamenla Q. Goka 3, and Jorgen A.L. Kurtzhals 4

1 Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, Accra, Ghana
2 Noguchi Memorial Institute for Medical Research, Legon, Ghana
3 Department of Child Health, Korle Bu Teaching Hospital, Accra, Ghana
4 Centre for Medical Parasitology, Department of Clinical Microbiology, Copenhagen University Hospital (Rigshospitalet), and Institute of Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark

* To whom correspondence should be addressed.
Neils Ben Quashie, E-mail: nquashie{at}noguchi.mimcom.net


   Abstract

A major manifestation of complicated malaria especially among children is severe anaemia, the pathogenesis of which is not well understood. Among other factors, suppression of the bone marrow's response to erythropoietin, which is rapidly reversed after successful treatment of the malaria, has been implicated in its pathogenesis. Since resolution of malaria restores erythropoiesis, we hypothesized that drug-resistant strains of Plasmodium falciparum would increase the risk of severe anaemia developing from initially uncomplicated malaria. Using both in vivo and in vitro drug-sensitivity tests we compared the prevalence of drug-resistant malaria between severe malarial anaemia (SA) and non-anaemic malaria (NAM) patients. Assessment of treatment outcome using the WHO in vivo criteria showed no significant difference in parasite resistance between the two groups. The mean parasite clearance time was also comparable. Treatment failures of about 14 per cent and 12 per cent were observed between SA and NAM patients respectively. The in vitro drug susceptibility test showed overall mean IC50 values of 0.41x10-6 mol/l and 0.32x10-6 mol/l blood for SA and NAM groups respectively. Geometric mean pre-treatment blood levels of chloroquine did not differ much between the two groups. Findings from this study could not therefore implicate drug-resistant parasites in the pathogenesis of severe malarial anaemia.


The figure label above fig 2 has been corrected so the labels appear over the correct gel lines.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.